虽然目前有多株益生菌表现出减重控脂的效果,但是当前益生菌调节代谢控制减重的临床试验还处于早期阶段,而且部分存在研究结果不一致的情况,因此需更多临床试验证实。不过,相信随着微生物技术进步创新,未来益生菌有机会成为干预肥胖的重要手段。 参考文献及资料:(滑动查看更多)1.李玲玉, 岳新新, 李力. 肠道菌群与代谢综合征相关性研究进展[J]. 中国民间疗法, 2020, 28(2):4.2.Sato M , Uzu K , Yoshida T , et al. Effects of milk fermented by Lactobacillus gasseri SBT2055 on adipocyte size in rats.[J]. British Journal of Nutrition, 2008, 99(05):1013-1017.3.Shirouchi B , Nagao K , Umegatani M , et al. Probiotic Lactobacillus gasseri SBT2055 improves glucose tolerance and reduces body weight gain in rats by stimulating energy expenditure[J]. British Journal of Nutrition, 2016, 116(03):451-458.4.Kadooka Y , Sato M , Imaizumi K , et al. Regulation of abdominal adiposity by probiotics (Lactobacillus gasseri SBT2055) in adults with obese tendencies in a randomized controlled trial[J]. European Journal of Clinical Nutrition, 2010, 64(6):636-643.5.Akihiro, Ogawa, Toshiya, et al. Lactobacillus gasseri SBT2055 suppresses fatty acid release through enlargement of fat emulsion size in vitro and promotes fecal fat excretion in healthy Japanese subjects.[J]. Lipids in Health & Disease, 2015.6.国枝由纪子, 濑户泰幸, 门冈幸男. 脂联素分泌促进和/或降低抑制剂: CN101883571A[P]. 2010.7.Kang J H , Yun S I , Park M H , et al. Anti-Obesity Effect of Lactobacillus gasseri BNR17 in High-Sucrose Diet-Induced Obese Mice[J]. Plos One, 2013, 8.8.Kim J , Yun J M , Mi K K , et al. Lactobacillus gasseri BNR17 Supplementation Reduces the Visceral Fat Accumulation and Waist Circumference in Obese Adults: A Randomized, Double-Blind, Placebo-Controlled Trial[J]. Journal of Medicinal Food, 2018, 21(5).9.Kang J H , You B I , Yun S I , et al. Lactic acid bacteria isolated from mother's milk with probiotic activity and inhibitory activity against body weight augmentation: EP, US8309076 B2[P]. 2018.10.Chen L H , Chen Y H , Cheng K C , et al. Antiobesity effect of Lactobacillus reuteri 263 associated with energy metabolism remodeling of white adipose tissue in high-energy-diet-fed rats.[J]. The Journal of Nutritional Biochemistry, 2017, 54:87-94.11.Hsieh F C , Lan C C E , Huang T Y , et al. Heat-killed and live Lactobacillus reuteri GMNL-263 exhibit similar effects on improving metabolic functions in high-fat diet-induced obese rats[J]. Food & Function, 2016:2374-2388.12.https://mp.weixin.qq.com/s/t1A36QzFojbR_ceTXaz32Q13.Hsieh M C , Tsai W H , Jheng Y P , et al. The beneficial effects of Lactobacillus reuteri ADR-1 or ADR-3 consumption on type 2 diabetes mellitus: a randomized, double-blinded, placebo-controlled trial[J]. Scientific Reports, 2018, 8(1).14.Leu Y C , FC Hsieh. Novel lactobacillus strain, composition and use thereof for improving the syndrome of diabetes and complication thereof: EP, EP2392340 A1[P]. 2013.15.Chen Y H , Hsieh F C , Chen P Y . Lactobacillus reuteri GMNL-263 composition for controlling body weight and its use thereof:ZL 201410012020.0[P]. 2015.16.Park S Y , Seong K S , Lim S D . Anti-obesity Effect of Yogurt Fermented by Lactobacillus plantarum Q180 in Diet-induced Obese Rats[J]. Korean Journal for Food Science of Animal Resources, 2016, 36(1):77-83.17.Ye E P , Min S K , Shim K W , et al. Effects of Lactobacillus plantarum Q180 on Postprandial Lipid Levels and Intestinal Environment: A Double-Blind, Randomized, Placebo-Controlled, Parallel Trial[J]. Nutrients, 2020, 12(1).18.https://mp.weixin.qq.com/s/WnRoQqkJtoSYKlzoWnlU6Q19.Amar J , Chabo C , Waget A , et al. Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic treatment[J]. EMBO Molecular Medicine, 2011, 3(9):559-572.20.Stenman L K , Waget A , Garret C , et al. Potential probiotic Bifidobacterium animalis ssp. lactis 420 prevents weight gain and glucose intolerance in diet-induced obese mice[J]. Beneficial Microbes, 2014, 5(4):437-445.21.Stenman L K , Lehtinen M J , Meland N , et al. Probiotic With or Without Fiber Controls Body Fat Mass, Associated With Serum Zonulin, in Overweight and Obese Adults—Randomized Controlled Trial[J]. EBioMedicine, 2016, 13(C).22.Uusitupa H M , Rasinkangas P , Lehtinen M J , et al. Bifidobacterium animalis subsp. lactis 420 for Metabolic Health: Review of the Research[J]. Nutrients, 2020, 12(4):892.23.L.斯登曼, S.拉缇恩. 用于降低食物,能量和/或脂肪摄入的双歧杆菌:CN109069554A[P]. 2018.24.Torres-Fuentes C, Golubeva AV, Zhdanov AV, Wallace S, Arboleya S, Papkovsky DB, El Aidy S, Ross P, Roy BL, Stanton C, Dinan TG, Cryan JF, Schellekens H. Short-chain fatty acids and microbiota metabolites attenuate ghrelin receptor signaling. FASEB J. 2019 Dec;33(12):13546-13559.Epub 2019 Oct 9. 25.Schellekens H, Torres-Fuentes C, van de Wouw M, et al. Bifidobacterium longum counters the effects of obesity: partial successful translation from rodent to human. EBioMedicine. 2020; 103176. 作者|EJOZO审校|617编辑|豫小鱼